-
1 Comment
Itamar Medical Ltd is currently in a long term uptrend where the price is trading 7.3% above its 200 day moving average.
From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.1.
Itamar Medical Ltd's total revenue rose by 30.8% to $13M since the same quarter in the previous year.
Its net income has dropped by 194.3% to $-3M since the same quarter in the previous year.
Finally, its free cash flow grew by 37.4% to $-1M since the same quarter in the previous year.
Based on the above factors, Itamar Medical Ltd gets an overall score of 4/5.
ISIN | US4654371016 |
---|---|
CurrencyCode | USD |
Industry | Medical Devices |
Sector | Healthcare |
Exchange | NASDAQ |
Target Price | 30.75 |
---|---|
Beta | 0.54 |
Dividend Yield | 0.0% |
PE Ratio | None |
Market Cap | 507M |
Itamar Medical Ltd., a medical technology company, develops and commercializes non-invasive medical devices and solutions for the treatment of respiratory sleep disorders. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enable to conduct home sleep apnea tests for the treatment of sleep apnea, such as obstructive sleep apnea; EndoPAT device that diagnoses endothelial dysfunction; and Loop device, a wrist device for measuring and recording physiological parameters, such as SpO2, respiration rate, and heart rate. The company operates in the United States, Canada, Europe, Israel, Japan, rest of the Asia Pacific, and internationally. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was incorporated in 1997 and is headquartered in Caesarea, Israel. As of December 16, 2021, Itamar Medical Ltd. operates as a subsidiary of ZOLL Medical Corporation.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ITMR using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024